BDNF and myeloid sarcoma: Several molecules such as BDNF, IL-1β, PDGF, and CB1Rs, are involved in functional recovery of MS from the acute phase and are thus taken as potential therapeutic targets (Ksiazek-Winiarek et al., 2015).